#Netherlands #Amsterdam #BMC Medical #Sleep Care #ERS 2025

BMC Medical's Innovations at ERS 2025

BMC Medical, a global leader in sleep and respiratory solutions, is gearing up for an exciting showcase of its latest product innovations at the prestigious European Respiratory Society (ERS) International Congress 2025, happening from September 28 to October 1 in Amsterdam. This year's event promises to be significant as BMC demonstrates its commitment to enhancing patient-centric care and clinical decision-making in the realm of sleep medicine.

Product Portfolio Highlights

At Booth H.13 in Hall 1, BMC will unveil three groundbreaking product innovations aimed at improving patient adherence and treatment efficacy:

1. 6S Series Mask: This next-generation mask is designed with enhanced comfort and fit, ensuring better patient compliance. Its innovative features cater to the specific needs of users, making it an ideal choice for those undergoing CPAP therapy.

2. G3 A20 CPAP Device: This state-of-the-art CPAP machine boasts improved adaptability and personalization options. It is engineered to optimize therapy results through individualized settings, providing patients with a more comfortable and effective treatment experience.

3. Home Sleep Testing Devices - YH-S900C and YH-S900B: These portable diagnostic devices are designed to facilitate accessible and accurate sleep testing from the comfort of home. They represent a significant advancement in diagnostic technology, making sleep studies more convenient for patients and health professionals alike.

In addition to the product showcases, BMC Medical will conduct an engaging workshop titled "The Future of CPAP Monitoring: What Needs to Change Today?" scheduled for September 15th. This session will feature industry experts, including:

• - Dr. Renata Riha from the University of Edinburgh, UK
• - Professor Jean-Louis Pépin from Grenoble University Hospital, France
• - Co-chairs Dr. Ding Zou from the University of Gothenburg, Sweden, and Dr. Abdelkebir Sabil, BMC's Global Medical Director, France.

The discussion will focus on transitioning from the traditional goal of four hours of nightly usage to an outcomes-based, phenotypically stratified CPAP treatment approach. Key topics will include integrating remote monitoring, artificial intelligence, and multi-modal data analytics to enhance long-term patient outcomes and reduce cardiovascular risks.

BMC Medical's Mission

Established in 2001, BMC Medical has dedicated itself to supporting families worldwide with high-quality products and professional services. Their goal is to proactively assist in alleviating the discomfort associated with chronic respiratory diseases. Through ongoing innovation and a steadfast commitment to improving patient care, BMC Medical remains at the forefront of advancements in the sleep and respiratory healthcare landscape.

As the ERS 2025 approaches, the anticipation for BMC Medical's presentation is mounting. Visitors to the congress can look forward to learning more about these innovative solutions and how they are set to transform the field of sleep medicine for countless patients around the globe.